CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA Talk title Deciphering Conserved Pluripotency Signaling Pathways Across Diverse Species Host Ian Chambers Abstract Establishing chimeric and germline-competent embryonic stem cells (ESCs) has been achieved in mice and rats, but it remains elusive for many other species. Over the past 15 years, our laboratory at the University of Southern California (USC) has dedicated efforts to derive authentic ESCs from a range of mammalian and avian species. In this presentation, I will unveil unpublished data detailing our progress in deriving ESCs across diverse species. I will also explore and discuss the common signaling pathways that we have identified as crucial and conserved for maintaining pluripotency across various species. Additionally, I will discuss our latest advancements in developing stem cell-based chimeric antigen receptor-macrophage (CAR-M) immunotherapy for cancer treatment. Bio Dr. Qi-Long Ying is a Professor in the Department of Stem Cell Biology and Regenerative Medicine and a founding member of the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at the University of Southern California (USC). He graduated from Southern Medical University, China, in 1987 with a BS degree in medicine. He then underwent training as a neurosurgeon at Shanghai Medical University, China. In 1995, he earned a PhD in molecular biology from Shanghai Medical University. From 1999 to 2006, he pursued postdoctoral studies under the guidance of Professor Austin Smith at the University of Edinburgh. Dr. Ying joined USC as a tenure-track assistant professor in 2006 and was promoted to associate professor with tenure in 2012, followed by a promotion to full professor in 2017. Dr. Ying's research primarily focuses on the expansion and therapeutic applications of embryonic and adult stem cells. He has received several awards and recognitions, including Science's Top 10 Breakthroughs of 2010, the 2011 Phi Kappa Phi Faculty Award at USC, and the 2016 McEwen Award for Innovation bestowed by the International Society for Stem Cell Research (ISSCR). Jan 25 2024 12.00 - 13.00 CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA This event is a Centre for Regenerative Medicine (CRM) external seminar which will take place in the seminar room, 1st floor, IRR North. Where to find us
CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA Talk title Deciphering Conserved Pluripotency Signaling Pathways Across Diverse Species Host Ian Chambers Abstract Establishing chimeric and germline-competent embryonic stem cells (ESCs) has been achieved in mice and rats, but it remains elusive for many other species. Over the past 15 years, our laboratory at the University of Southern California (USC) has dedicated efforts to derive authentic ESCs from a range of mammalian and avian species. In this presentation, I will unveil unpublished data detailing our progress in deriving ESCs across diverse species. I will also explore and discuss the common signaling pathways that we have identified as crucial and conserved for maintaining pluripotency across various species. Additionally, I will discuss our latest advancements in developing stem cell-based chimeric antigen receptor-macrophage (CAR-M) immunotherapy for cancer treatment. Bio Dr. Qi-Long Ying is a Professor in the Department of Stem Cell Biology and Regenerative Medicine and a founding member of the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at the University of Southern California (USC). He graduated from Southern Medical University, China, in 1987 with a BS degree in medicine. He then underwent training as a neurosurgeon at Shanghai Medical University, China. In 1995, he earned a PhD in molecular biology from Shanghai Medical University. From 1999 to 2006, he pursued postdoctoral studies under the guidance of Professor Austin Smith at the University of Edinburgh. Dr. Ying joined USC as a tenure-track assistant professor in 2006 and was promoted to associate professor with tenure in 2012, followed by a promotion to full professor in 2017. Dr. Ying's research primarily focuses on the expansion and therapeutic applications of embryonic and adult stem cells. He has received several awards and recognitions, including Science's Top 10 Breakthroughs of 2010, the 2011 Phi Kappa Phi Faculty Award at USC, and the 2016 McEwen Award for Innovation bestowed by the International Society for Stem Cell Research (ISSCR). Jan 25 2024 12.00 - 13.00 CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA This event is a Centre for Regenerative Medicine (CRM) external seminar which will take place in the seminar room, 1st floor, IRR North. Where to find us
Jan 25 2024 12.00 - 13.00 CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA CRM External Seminar: Qilong Ying, Professor of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, USA
